US Medical Aesthetics Market Size Likely to Surpass at a CAGR of 7.1% By 2033

As per the current market research conducted by the CMI Team, the US Medical Aesthetics Market size is expected to record a CAGR of 7.1% from 2024 to 2033. In 2024, the market size is projected to reach a valuation of USD 6,127.7 Million. By 2033, the valuation is anticipated to reach USD 11,360.7 Million.

US Medical Aesthetics Market: Growth Factors and Dynamics

• Technological Advancements: The US Medical Aesthetics Market is driven by continuous technological advancements in cosmetic procedures and devices. Innovations such as laser technology, radiofrequency devices, and minimally invasive procedures contribute to the market’s growth by offering safer, more effective, and less invasive treatment options for patients.

• Growing Demand for Non-Invasive Procedures: There is a rising demand for non-invasive and minimally invasive aesthetic procedures in the US, driven by factors such as increasing awareness of aesthetic treatments, rising disposable income, and a growing aging population. Procedures like Botox injections, dermal fillers, and laser hair removal are popular due to their minimal downtime and natural-looking results.

• Increasing Acceptance of Aesthetic Treatments: The stigma associated with aesthetic treatments is diminishing, leading to increased acceptance and adoption among a broader demographic. Men, in particular, are increasingly seeking cosmetic procedures to enhance their appearance, contributing to market growth.

• Expanding Aesthetic Industry: The US Medical Aesthetics Market is experiencing rapid expansion, fueled by the entry of new players, including medical spas, aesthetic clinics, and online platforms offering aesthetic services. This increased competition drives innovation, promotes price competitiveness, and expands access to aesthetic treatments.

• Influence of Social Media and Celebrity Culture: Social media and celebrity culture play a significant role in driving demand for aesthetic treatments. Platforms like Instagram and TikTok showcase idealized beauty standards, influencing individuals to seek cosmetic enhancements to achieve similar looks. Celebrity endorsements and influencer marketing further contribute to the market’s growth by normalizing aesthetic procedures.

• Regulatory Landscape and Safety Concerns: Regulatory oversight, such as FDA approvals and state licensure requirements, ensures patient safety and quality standards in the US Medical Aesthetics Market. However, safety concerns, including adverse events and complications associated with aesthetic procedures, remain a challenge. Maintaining high safety standards and ensuring adequate provider training and patient education are essential for sustaining market growth.

• Shift Towards Preventative Treatments: There is a growing trend towards preventative aesthetic treatments aimed at preserving youthfulness and preventing signs of aging before they become prominent. This shift is driven by a desire for natural-looking results and the recognition that early intervention can delay the need for more invasive procedures later in life.

US Medical Aesthetics Market: Partnership and Acquisitions

• In 2022, Apyx Medical received FDA clearance for the Renuvion device to be used in aesthetic procedures targeting lax skin in the neck region. This clearance expands the device’s applications, offering patients innovative options for enhancing their appearance.

• In 2022, Allergan, a subsidiary of AbbVie Inc., secured FDA approval for JUVÉDERM VOLBELLA XC to enhance infraorbital hollows in adults over 21. This expansion of their aesthetics product portfolio strengthens their position in the U.S. market

Report Scope

US Medical Aesthetics Market: COVID-19 Analysis

The COVID-19 pandemic has significantly impacted the US Medical Aesthetics Market, with the industry experiencing both positive and negative effects. Here are some of the key impacts:

• Temporary Closure of Aesthetic Clinics: During the height of the pandemic, many aesthetic clinics and medical spas in the US were forced to temporarily close or reduce operations due to government-mandated lockdowns and safety concerns. This led to a significant decline in patient volume and revenue for aesthetic practitioners.

• Postponement of Elective Procedures: As elective procedures were put on hold to prioritize urgent medical needs and minimize the risk of COVID-19 transmission, patients postponed aesthetic treatments such as Botox injections, dermal fillers, and laser treatments. This resulted in decreased demand for aesthetic services and a slowdown in market growth.

• Pent-up Demand and Resurgence of Procedures: With the easing of pandemic restrictions and the rollout of vaccination campaigns, there has been a resurgence in demand for aesthetic treatments in the US. Patients who deferred procedures during the pandemic are now seeking treatment, leading to a rebound in patient volume and revenue for aesthetic practices.

• Adoption of Telemedicine and Virtual Consultations: Aesthetic practitioners have embraced telemedicine and virtual consultations as a way to connect with patients remotely during the pandemic. By offering virtual consultations, practitioners can assess patient needs, provide treatment recommendations, and schedule appointments, thereby expanding access to aesthetic services and facilitating patient engagement.

• Focus on Safety and Hygiene Protocols: Aesthetic clinics and medical spas have implemented stringent safety and hygiene protocols to reassure patients and mitigate the risk of COVID-19 transmission. Measures such as enhanced cleaning procedures, social distancing, and personal protective equipment (PPE) usage instill confidence in patients and demonstrate a commitment to their health and safety.

• Introduction of Touchless Technologies: To minimize physical contact and reduce the risk of virus transmission, aesthetic practices are adopting touchless technologies and digital solutions. Touchless check-in processes, online appointment scheduling, and contactless payment options enhance the patient experience and streamline clinic operations while prioritizing safety.

• Diversification of Service Offerings: Aesthetic practitioners are diversifying their service offerings to meet evolving patient needs and preferences. This includes introducing new treatments, such as skin rejuvenation procedures, body contouring treatments, and wellness services, to attract a broader patient base and generate additional revenue streams in the post-pandemic landscape.

In conclusion, the COVID-19 pandemic has had a mixed impact on the US Medical Aesthetics Market, with some challenges and opportunities arising from the pandemic.

List of the prominent players in the US Medical Aesthetics Market:

• Allergan Inc. (a subsidiary of AbbVie Inc.)
• Galderma Laboratories L.P.
• Merz Pharma GmbH & Co. KGaA
• Alma Lasers Ltd. (a subsidiary of Sisram Medical Ltd.)
• Cynosure LLC (a subsidiary of Hologic Inc.)
• Syneron Candela Corporation (a subsidiary of Apax Partners)
• Solta Medical Inc. (a subsidiary of Bausch Health Companies Inc.)
• Cutera Inc.
• Lumenis Ltd. (a subsidiary of XIO Group)
• Sciton Inc.
• Zimmer Biomet Holdings Inc.
• Venus Concept Ltd.
• Hologic Inc.
• Sientra Inc.
• InMode Ltd.
• Others

The US Medical Aesthetics Market is segmented as follows:

By Product Type

• Aesthetic Laser Devices
• Energy Devices
• Body Contouring Devices
• Facial Aesthetic Devices
• Aesthetic Implants
• Skin Aesthetic Devices

By Application

• Anti-Aging and Wrinkles
• Facial and Skin Rejuvenation
• Breast Enhancement
• Body Shaping and Cellulite
• Tattoo Removal
• Vascular Lesions
• Sears
• Pigment Lesions
• Reconstructive
• Psoriasis and Vitiligo
• Others

By End User

• Cosmetic Centers
• Dermatology Clinics
• Hospitals
• Medical Spas
• Beauty Centers
• Others

By Distribution Channel

• Direct Sale
• Retail Sales
• Others